BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Visa
V
|
+$231M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$145M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$63M |
| 4 |
Pinterest
PINS
|
+$53.4M |
| 5 |
Prologis
PLD
|
+$50.8M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$4.18B |
| 2 |
Apple
AAPL
|
+$1.93B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.78B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.36B |
| 5 |
Microsoft
MSFT
|
+$1.2B |
Sector Composition
| 1 | Technology | 16.91% |
| 2 | Consumer Discretionary | 12.65% |
| 3 | Financials | 12.2% |
| 4 | Healthcare | 8.11% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNCB
3001
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $26.7K | ﹤0.01% |
4,176
-73
| -2% | -$467 |
|
3002
Plumas Bancorp
PLBC
$324M
| $26.6K | ﹤0.01% |
1,134
+77
| +7% | +$1.81K |
|
|
CBIO
3003
Crescent Biopharma, Inc. Common Stock
CBIO
$176M
| $26.5K | ﹤0.01% |
71
-15
| -17% | -$5.61K |
|
3004
Tenaris
TS
$18.7B
| $26.5K | ﹤0.01% |
1,662
-417
| -20% | -$6.65K |
|
3005
Kezar Life Sciences
KZR
$29.7M
| $26.4K | ﹤0.01% |
505
-168
| -25% | -$8.77K |
|
3006
iRadimed
IRMD
$932M
| $26.2K | ﹤0.01% |
1,150
-257
| -18% | -$5.86K |
|
3007
Paysign
PAYS
$292M
| $26.1K | ﹤0.01% |
5,625
-1,162
| -17% | -$5.39K |
|
3008
Weyco Group
WEYS
$284M
| $26K | ﹤0.01% |
1,640
+147
| +10% | +$2.33K |
|
3009
First Community Corp
FCCO
$216M
| $25.9K | ﹤0.01% |
1,524
+139
| +10% | +$2.36K |
|
3010
United Security Bancshares
UBFO
$167M
| $25.8K | ﹤0.01% |
3,660
+45
| +1% | +$317 |
|
3011
First Guaranty Bancshares
FGBI
$125M
| $25.4K | ﹤0.01% |
1,575
+443
| +39% | +$7.16K |
|
3012
Canadian Pacific Kansas City
CP
$68.8B
| $25.3K | ﹤0.01% |
365
-225
| -38% | -$15.6K |
|
3013
ADMA Biologics
ADMA
$3.9B
| $25.3K | ﹤0.01% |
12,950
-1,478
| -10% | -$2.88K |
|
3014
Vitamin Cottage Natural Grocers
NGVC
$867M
| $25.2K | ﹤0.01% |
1,834
-590
| -24% | -$8.11K |
|
3015
Priority Technology Holdings
PRTH
$611M
| $24.8K | ﹤0.01% |
3,525
-637
| -15% | -$4.48K |
|
3016
Ohio Valley Banc Corp
OVBC
$173M
| $24.6K | ﹤0.01% |
1,042
+145
| +16% | +$3.42K |
|
3017
Gyre Therapeutics
GYRE
$760M
| $24.5K | ﹤0.01% |
518
-139
| -21% | -$6.58K |
|
|
GRTS
3018
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $24.4K | ﹤0.01% |
6,192
-1,091
| -15% | -$4.3K |
|
3019
Esquire Financial Holdings
ESQ
$833M
| $24.4K | ﹤0.01% |
1,271
-201
| -14% | -$3.86K |
|
3020
Electromed
ELMD
$204M
| $24.3K | ﹤0.01% |
2,476
+921
| +59% | +$9.04K |
|
|
RESN
3021
DELISTED
Resonant Inc.
RESN
| $24.2K | ﹤0.01% |
9,116
-1,940
| -18% | -$5.14K |
|
|
AGFS
3022
DELISTED
AgroFresh Solutions, Inc. Common Stock
AGFS
| $24.1K | ﹤0.01% |
10,618
+3,878
| +58% | +$8.8K |
|
3023
Gencor Industries
GENC
$228M
| $24K | ﹤0.01% |
1,949
-90
| -4% | -$1.11K |
|
3024
Eton Pharmaceutcials
ETON
$477M
| $24K | ﹤0.01% |
2,947
-201
| -6% | -$1.63K |
|
3025
Saga Communications
SGA
$77.2M
| $23.7K | ﹤0.01% |
986
+74
| +8% | +$1.78K |
|